Gardiner Healthcare Acquisitions Corp. (GDNR) Stock Analysis
DELISTED 2023
What happened to Gardiner Healthcare Acquisitions Corp. (GDNR) stock?
Gardiner Healthcare Acquisitions Corp. (GDNR) no longer trades on public markets. It was delisted in December 2023. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Gardiner Healthcare Acquisitions Corp. (GDNR) trades at $10.90. Gardiner Healthcare Acquisitions Corp. is a shell company focused on acquiring a business in the healthcare or related industries. Market cap: $41.0M, Sector: Financial services.
Last analyzed: Mar 17, 2026Analyst Coverage for GDNR: GDNR does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GDNR against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
GDNR: 2/2 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Gardiner Healthcare Acquisitions Corp. (GDNR) Financial Services Profile
Gardiner Healthcare Acquisitions Corp., a special purpose acquisition company (SPAC), targets businesses within the healthcare sector for potential mergers or acquisitions. With a market capitalization of $41.0M and a high P/E ratio, GDNR seeks to identify and secure a strategic business combination to create shareholder value.
What Is the Investment Thesis for GDNR?
Gardiner Healthcare Acquisitions Corp. presents a speculative investment opportunity, contingent on its ability to identify and successfully merge with a promising healthcare company. With a market capitalization of $41.0M and a P/E ratio of 261.2, the company's valuation is heavily reliant on the potential of a future acquisition. The absence of a dividend reflects its current operational status as a shell company. The primary value driver is the management team's expertise in sourcing and executing a merger within the healthcare sector. A successful acquisition could lead to significant shareholder value creation, while failure to do so poses a substantial risk. Investors should closely monitor the company's progress in identifying and securing a suitable target, as well as the terms and potential synergies of any proposed transaction. The timeline for a potential merger is uncertain, adding to the speculative nature of the investment.
Based on FMP financials and quantitative analysis
GDNR Key Highlights
Market capitalization of $41.0M reflects its status as a special purpose acquisition company (SPAC).
- P/E ratio of 261.2 indicates high investor expectations pending a successful acquisition.
- The company was incorporated in 2021, indicating a relatively new entity in the SPAC market.
- Focus on healthcare and related industries provides a specific target area for potential acquisitions.
- No dividend is currently offered, consistent with the company's focus on identifying and acquiring a target business.
Who Are GDNR's Competitors?
GDNR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ACBA Ace Global Business Acquisition Limited | $12.03 | -0.58% | $41.3M | 44 |
| AIB AIB Acquisition Corporation | $1.33 | -7.64% | $101M | — |
| OTEC OceanTech Acquisitions I Corp. | $11.75 | +0.43% | $41.1M | 44 |
| INACU Indigo Acquisition Corp. | $12.08 | +16.94% | $34.9M | 60 |
| HHGC HHG Capital Corporation | $11.12 | +0.09% | $56.2M | 63 |
| CLAY Chavant Capital Acquisition Corp. | $10.66 | +6.39% | $29.6M | 62 |
| MAAQ Mana Capital Acquisition Corp. | $5.99 | -24.18% | $57.0M | 61 |
| CLAYU Chavant Capital Acquisition Corp. | $10.97 | +18.34% | $27.5M | 62 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GDNR's Key Strengths?
Experienced management team with healthcare industry expertise.
- Access to capital through public markets.
- Flexibility to pursue a wide range of acquisition targets.
- Potential for high returns if a successful acquisition is completed.
What Are GDNR's Weaknesses?
No current operations or revenue.
- Dependent on identifying and acquiring a suitable target company.
- Subject to regulatory scrutiny and market volatility.
- Intense competition from other SPACs.
What Could Drive GDNR Stock Higher?
Announcement of a definitive agreement to acquire a target company in the healthcare sector.
- Progress in due diligence and negotiations with potential target companies.
- Changes in the regulatory landscape that could impact the healthcare industry and acquisition opportunities.
What Are the Key Risks for GDNR?
Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Rich valuation — a P/E of 261.2 runs well above the Financial Services sector’s ~18x, leaving little room for a miss.
- Failure to identify and acquire a suitable target company within the specified timeframe.
- Unfavorable market conditions or regulatory changes that could impact the value of potential acquisitions.
- Inability to raise additional capital to finance acquisitions.
- Competition from other SPACs for attractive acquisition targets.
What Are the Growth Opportunities for GDNR?
- Successful Acquisition: The primary growth opportunity lies in identifying and acquiring a high-growth healthcare company. A successful acquisition could provide Gardiner Healthcare Acquisitions Corp. with immediate revenue and earnings, transforming it from a shell company into an operating business. The timeline for this opportunity is dependent on the company's ability to source and negotiate a deal, with potential for completion within the next 12-24 months.
- Strategic Partnerships: Forming strategic partnerships with healthcare industry experts and venture capital firms can enhance deal-sourcing capabilities and provide access to a wider range of potential targets. These partnerships can also provide valuable due diligence and operational expertise, increasing the likelihood of a successful acquisition. The timeline for establishing such partnerships is relatively short, with potential agreements within the next 6-12 months.
- Expansion into Related Healthcare Verticals: Once a core healthcare business is acquired, Gardiner Healthcare Acquisitions Corp. can explore expansion into related verticals, such as pharmaceuticals, medical devices, or healthcare technology. This diversification can reduce risk and create synergies, driving long-term growth. The timeline for this expansion is dependent on the performance of the initial acquisition, with potential for expansion within 3-5 years.
- Geographic Expansion: Expanding the acquired healthcare business into new geographic markets can drive revenue growth and increase market share. This can be achieved through organic growth or through strategic acquisitions of complementary businesses in new regions. The timeline for geographic expansion is dependent on the performance of the initial acquisition and the availability of suitable targets, with potential for expansion within 3-5 years.
- Operational Improvements: Implementing operational improvements within the acquired healthcare business can increase efficiency, reduce costs, and improve profitability. This can include streamlining processes, investing in technology, and optimizing the supply chain. The timeline for implementing these improvements is ongoing, with continuous efforts to enhance operational performance.
What Are GDNR's Competitive Advantages?
- Management team's expertise in the healthcare industry.
- Access to capital through the public markets.
- Ability to provide a faster and less complex path to public listing for private companies.
- Established network of industry contacts and potential target companies.
What Does GDNR Do?
Gardiner Healthcare Acquisitions Corp. was founded in 2021 and is based in Shaker Heights, Ohio. As a special purpose acquisition company (SPAC), Gardiner Healthcare Acquisitions Corp. does not have significant operations. Its primary objective is to identify and acquire a business in the healthcare or healthcare-related industries through a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination. The company's strategy revolves around leveraging the expertise of its management team to pinpoint a target company with strong growth potential within the healthcare sector. Once a target is identified, Gardiner Healthcare Acquisitions Corp. aims to complete a transaction that will bring the target company into the public market, providing it with access to capital and enhanced visibility. The success of Gardiner Healthcare Acquisitions Corp. hinges on its ability to identify and execute a value-accretive transaction within the healthcare industry, which is subject to regulatory changes and competitive pressures.
What Products and Services Does GDNR Offer?
- Identify potential acquisition targets in the healthcare or healthcare-related industries.
- Conduct due diligence on potential target companies.
- Negotiate and structure merger, share exchange, or asset acquisition agreements.
- Raise capital to finance acquisitions.
- Manage the integration of acquired businesses.
- Create shareholder value through successful acquisitions and operational improvements.
How Does GDNR Make Money?
- Operates as a special purpose acquisition company (SPAC).
- Raises capital through an initial public offering (IPO).
- Seeks to acquire a private company in the healthcare sector.
- Generates returns for shareholders through the appreciation of the acquired company's stock.
What Industry Does GDNR Operate In?
Gardiner Healthcare Acquisitions Corp. operates within the shell company industry, specifically targeting the healthcare sector. The SPAC market has experienced significant growth in recent years, driven by companies seeking a faster and less complex path to public listing compared to traditional IPOs. The healthcare industry remains a popular target for SPACs due to its growth potential and innovation. However, the SPAC market is also subject to regulatory scrutiny and market volatility, which can impact the success of these companies. Competition among SPACs for attractive targets is intense, requiring companies like Gardiner Healthcare Acquisitions Corp. to differentiate themselves through sector expertise and deal-sourcing capabilities.
Who Are GDNR's Key Customers?
- Investors seeking exposure to the healthcare sector through a SPAC.
- Private healthcare companies seeking to go public through a merger with a SPAC.
- Institutional investors looking for opportunities in the SPAC market.
Financial Health
Gardiner Healthcare Acquisitions Corp.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 9.02 places it in the safe zone, indicating low near-term bankruptcy risk.
Key Financial Metrics
Return on equity for Gardiner Healthcare Acquisitions Corp. stands at 0.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.2%, showing how much profit it generates from its asset base. GDNR trades at a trailing price-to-earnings ratio of 261.24, above the Financial Services sector average of ~18x. Its free cash flow yield is -3.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.19 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.4%, the inverse of the P/E and a quick read on earnings relative to price.
GDNR Valuation & Market Position
With a $41.0M market cap, Gardiner Healthcare Acquisitions Corp. sits in the micro-cap segment of the market.
GDNR Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Experienced management team with healthcare industry expertise.
- Access to capital through public markets.
- Flexibility to pursue a wide range of acquisition targets.
- Potential for high returns if a successful acquisition is completed.
Bear Case
- No current operations or revenue.
- Dependent on identifying and acquiring a suitable target company.
- Subject to regulatory scrutiny and market volatility.
- Intense competition from other SPACs.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
GDNR Latest News
No recent news available for GDNR.
Classification
Industry Shell CompaniesLeadership: Marc F. Pelletier
CEO
Marc F. Pelletier serves as the CEO of Gardiner Healthcare Acquisitions Corp. His background includes extensive experience in the financial services and healthcare industries. Pelletier has held various leadership positions in investment banking and private equity firms, where he focused on mergers and acquisitions, capital raising, and strategic advisory services for healthcare companies. He has a proven track record of identifying and executing successful transactions in the healthcare sector. Pelletier's expertise spans across various healthcare sub-sectors, including pharmaceuticals, medical devices, healthcare services, and healthcare technology. His experience positions him well to lead Gardiner Healthcare Acquisitions Corp. in its pursuit of a suitable acquisition target.
Track Record: Under Marc F. Pelletier's leadership, Gardiner Healthcare Acquisitions Corp. has focused on identifying and evaluating potential acquisition targets within the healthcare industry. While the company has not yet completed an acquisition, Pelletier has overseen the development of a robust deal-sourcing process and has engaged with numerous potential target companies. His strategic decisions have focused on identifying companies with strong growth potential and attractive valuations. Pelletier's efforts have been instrumental in positioning Gardiner Healthcare Acquisitions Corp. to execute a successful acquisition in the future.
What Investors Ask About Gardiner Healthcare Acquisitions Corp. (GDNR) — Financial Services
What happened to Gardiner Healthcare Acquisitions Corp. (GDNR) stock?
Gardiner Healthcare Acquisitions Corp. (GDNR) no longer trades on public markets. It was delisted in December 2023. The figures below are historical and are not a current quote.
Can I still buy GDNR shares?
No. GDNR stopped trading on public markets in December 2023, so the shares are not available through a broker. Anything you see quoted for GDNR elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before GDNR stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Gardiner Healthcare Acquisitions Corp.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Gardiner Healthcare Acquisitions Corp. do?
Gardiner Healthcare Acquisitions Corp. is a special purpose acquisition company (SPAC) focused on acquiring a business in the healthcare or healthcare-related industries. As a shell company, it has no current operations and exists solely to identify and merge with a private healthcare company, bringing it into the public market.
What do analysts say about GDNR stock?
As a SPAC, Gardiner Healthcare Acquisitions Corp. (GDNR) is subject to limited analyst coverage until it announces a definitive agreement to acquire a target company. The stock's performance is primarily driven by speculation surrounding potential acquisition targets and the management team's ability to execute a successful transaction.
What are the main risks for GDNR?
The main risks for Gardiner Healthcare Acquisitions Corp. include the failure to identify and acquire a suitable target company within the specified timeframe, which could lead to the liquidation of the SPAC and a loss of investment for shareholders.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The analysis is based on limited information available for a special purpose acquisition company (SPAC).
- The success of Gardiner Healthcare Acquisitions Corp. is highly dependent on its ability to identify and acquire a suitable target company.
- The healthcare industry is subject to regulatory changes and market volatility, which could impact the company's prospects.